Text and Data Mining valid from 2016-08-01
Received: 10 February 2016
Accepted: 5 July 2016
First Online: 3 August 2016
: D.M.S. is a founder and member of the Scientific Advisory Board, a paid consultant, and a shareholder of Navitor Pharmaceuticals, which is targeting for therapeutic benefit the amino-acid-sensing pathway upstream of mTORC1.